Gateway Investment Advisers LLC Edwards Lifesciences Corp Transaction History

Gateway Investment Advisers LLC

  • $9 Billion
  • Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 5,855 shares of EW stock, worth $396,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,855
Previous 182,910 96.8%
Holding current value
$396,734
Previous $16.9 Million 97.72%
% of portfolio
0.0%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$59.7 - $93.78 $10.6 Million - $16.6 Million
-177,055 Reduced 96.8%
5,855 $386,000
Q2 2024

Jul 12, 2024
SELL
$84.3 - $94.31 $1.74 Million - $1.94 Million
-20,614 Reduced 10.13%
182,910 $16.9 Million
Q1 2024

Apr 12, 2024
SELL
$72.54 - $95.56 $3.61 Million - $4.76 Million
-49,813 Reduced 19.66%
203,524 $19.4 Million
Q4 2023

Jan 09, 2024
BUY
$61.71 - $77.76 $1.7 Million - $2.14 Million
27,519 Added 12.19%
253,337 $19.3 Million
Q3 2023

Oct 19, 2023
SELL
$69.28 - $93.38 $41,498 - $55,934
-599 Reduced 0.26%
225,818 $15.6 Million
Q2 2023

Jul 13, 2023
BUY
$81.41 - $94.33 $895 - $1,037
11 Added 0.0%
226,417 $21.4 Million
Q1 2023

Apr 11, 2023
SELL
$74.26 - $84.51 $281,965 - $320,884
-3,797 Reduced 1.65%
226,406 $18.7 Million
Q4 2022

Jan 13, 2023
BUY
$68.3 - $87.44 $316,160 - $404,759
4,629 Added 2.05%
230,203 $0
Q3 2022

Oct 07, 2022
SELL
$82.37 - $107.29 $3.68 Million - $4.79 Million
-44,663 Reduced 16.53%
225,574 $18.6 Million
Q2 2022

Jul 13, 2022
BUY
$86.5 - $128.27 $2.93 Million - $4.35 Million
33,877 Added 14.33%
270,237 $25.7 Million
Q1 2022

Apr 14, 2022
SELL
$101.96 - $128.34 $3.31 Million - $4.17 Million
-32,458 Reduced 12.07%
236,360 $27.8 Million
Q4 2021

Jan 14, 2022
SELL
$106.37 - $130.68 $77,543 - $95,265
-729 Reduced 0.27%
268,818 $34.8 Million
Q3 2021

Oct 22, 2021
SELL
$102.91 - $122.75 $33,651 - $40,139
-327 Reduced 0.12%
269,547 $30.5 Million
Q2 2021

Jul 13, 2021
SELL
$83.84 - $104.76 $51,393 - $64,217
-613 Reduced 0.23%
269,874 $28 Million
Q1 2021

Apr 14, 2021
SELL
$78.68 - $90.67 $508,902 - $586,453
-6,468 Reduced 2.34%
270,487 $22.6 Million
Q4 2020

Jan 14, 2021
BUY
$71.69 - $91.23 $156,642 - $199,337
2,185 Added 0.8%
276,955 $25.3 Million
Q3 2020

Oct 19, 2020
SELL
$67.19 - $87.44 $6,786 - $8,831
-101 Reduced 0.04%
274,770 $21.9 Million
Q2 2020

Jul 15, 2020
BUY
$57.54 - $76.95 $10 Million - $13.4 Million
174,422 Added 173.64%
274,871 $19 Million
Q1 2020

Apr 13, 2020
BUY
$52.41 - $81.0 $562,988 - $870,102
10,742 Added 11.97%
100,449 $18.9 Million
Q4 2019

Jan 09, 2020
SELL
$71.7 - $82.09 $683,802 - $782,892
-9,537 Reduced 9.61%
89,707 $20.9 Million
Q3 2019

Oct 15, 2019
SELL
$61.55 - $75.43 $994,524 - $1.22 Million
-16,158 Reduced 14.0%
99,244 $21.8 Million
Q2 2019

Jul 17, 2019
SELL
$55.74 - $64.41 $23,076 - $26,665
-414 Reduced 0.36%
115,402 $21.3 Million
Q1 2019

Apr 10, 2019
SELL
$47.89 - $64.05 $278,911 - $373,027
-5,824 Reduced 4.79%
115,816 $22.2 Million
Q4 2018

Jan 14, 2019
BUY
$46.41 - $56.94 $5.2 Million - $6.38 Million
112,000 Added 1161.83%
121,640 $18.6 Million
Q3 2018

Oct 16, 2018
SELL
$45.7 - $58.03 $7,266 - $9,226
-159 Reduced 1.62%
9,640 $1.68 Million
Q2 2018

Jul 11, 2018
SELL
$42.45 - $51.3 $53,826 - $65,048
-1,268 Reduced 11.46%
9,799 $1.43 Million
Q1 2018

Apr 12, 2018
SELL
$37.19 - $47.45 $48,309 - $61,637
-1,299 Reduced 10.5%
11,067 $1.54 Million
Q4 2017

Jan 17, 2018
SELL
$33.79 - $39.39 $32,607 - $38,011
-965 Reduced 7.24%
12,366 $1.39 Million
Q3 2017

Oct 16, 2017
BUY
$36.29 - $38.83 $483,781 - $517,642
13,331
13,331 $1.46 Million

Others Institutions Holding EW

# of Institutions
1,351
Shares Held
455M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email